Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2010
11/17/2010CN1772089B Freeze dried oldenlandia powder for injection and its preparation method
11/17/2010CN101888840A Method of treating polycystic kidney diseases with ceramide derivatives
11/17/2010CN101884789A Ctgf as target for the therapy of diabetic nephropathy
11/17/2010CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity
11/17/2010CN101884770A Chinese medicinal preparation for treating urolithiasis and preparation method thereof
11/17/2010CN101884767A Plant extract composite for preventing diabetes complication and senium and preparation method thereof
11/17/2010CN101884766A Healthcare product or medicine for preventing diabetes complication and senium and preparation method thereof
11/17/2010CN101884765A Medicament for treating big belly known as beer belly
11/17/2010CN101884759A Kidney-warming, yang-strengthening and health-preserving medicinal liquor and preparation method thereof
11/17/2010CN101884757A Food therapy preparation for preventing and treating nephropathy based on theories of preventive treatment of disease and medicine food homology
11/17/2010CN101884752A Chinese medicinal preparation for navel plaster and preparation method thereof
11/17/2010CN101884747A Traditional Chinese medicine for treating chronic nephritis
11/17/2010CN101884734A Chinese medicinal composition for treating dribbling urination
11/17/2010CN101884722A Medicament for treating chyluria and preparation method thereof
11/17/2010CN101884718A Medicament for treating prostatitis
11/17/2010CN101884670A Cake for treating postpartum urine without cease
11/17/2010CN101884669A Traditional Chinese medicine for treating renal calculus
11/17/2010CN101884641A Method for building animal model for treating chronic renal injury by using traditional Chinese medicine
11/17/2010CN101357224B Kidney-tonifying and health-preserving preparation
11/17/2010CN101301284B Uses of emodic acid or salt thereof for treating chronic nephritis or chronic renal failure
11/17/2010CN101244166B Method of preparing Chinese medicine for treating acute pyelonephritis of adults
11/17/2010CN101234150B Pharmaceutical composition for foaming elimination poison and promoting menstruation and dissipating mass and preparation thereof
11/17/2010CN101130030B Medicine composition for treating nephropathy and uses of the same
11/17/2010CN101091705B Application of compounds in isorhodanic ester classes for treating diseases of prostate and skin cancer
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834006 antidiabetics; lower blood glucose levels; compounds based on 1H,2H,3H,4H,5H,6H,7H,8H-pyrrolo[3,4-e][1,4]diazepin-6-one
11/16/2010US7833742 Fabry disease; X-linked inherited lysosomal storage disease characterized by severe renal impairment, angiokeratomas, and/or cardiovascular abnormalities; selecting a human alpha -Gal A preparation having a desired pharmacokinetic parameter
11/16/2010CA2532714C Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
11/16/2010CA2471220C Novel alkansulfonamides as endothelin antagonists
11/16/2010CA2452114C Tgf-.beta. superfamily production/secretion promoter
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2415643C Pharmaceutical composition for oral use with improved absorption
11/16/2010CA2315878C Kappa receptor opioid peptides
11/11/2010WO2010127440A1 Substituted aromatic compounds and pharmaceutical uses thereof
11/11/2010WO2010001179A3 Calcium ion channel modulators & uses thereof
11/11/2010WO2009135581A9 Nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
11/11/2010US20100286630 Method For Treating Overactive Bladders And A Device For Storage And Administration Of Topical Oxybutynin Compositions
11/11/2010US20100286275 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
11/11/2010US20100286269 Medium-Chain Length Fatty Acids and Glycerides as Nephroprotection Agents
11/11/2010US20100286260 Milnacipran formulations
11/11/2010US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
11/11/2010US20100286231 Method for identifying a renal fibrosis process use of snail- activity-inhibiting compounds in the production of pharmaceutical compositions, method for identifying said inhibiting compounds, said pharmaceutical compositions and applications thereof
11/11/2010US20100286223 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
11/11/2010US20100286197 Carboxamide Derivatives As Therapeutic Agents
11/11/2010US20100286181 Pyrrole derivatives with antibacterial activity
11/11/2010US20100286174 Inhibiting gsnor
11/11/2010US20100286149 Novel benzamide derivatives useful as potassium channel modulators
11/11/2010US20100286129 Novel benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
11/11/2010US20100286123 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100286120 Pyridooxazepine derivative and use thereof
11/11/2010US20100286119 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
11/11/2010US20100286106 Methods and apparatus for treating the prostate
11/11/2010US20100286063 GNRH agonist combination drugs
11/11/2010US20100286049 Polycystic kidney disease-related gene and use thereof
11/11/2010US20100286045 Methods comprising desmopressin
11/11/2010US20100286029 Use of a peptide as a therapeutic agent
11/11/2010US20100285158 Effervescent composition including cranberry extract
11/11/2010US20100285117 Combination of triazine derivatives and insulin sensitisers
11/11/2010US20100285073 a micro-rna family that modulates fibrosis and uses thereof
11/11/2010US20100285009 Humanized anti-egfl7 antibodies and methods using same
11/11/2010US20100284974 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
11/11/2010US20100284913 Methods and compositions for studying, imaging, and treating pain
11/11/2010CA2821174A1 A method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
11/11/2010CA2761018A1 Substituted aromatic compounds and pharmaceutical uses thereof
11/10/2010EP2248524A2 Preventives/remedies for stress urinary incontinence and method of screening the same
11/10/2010EP2247575A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
11/10/2010EP2247285A2 Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose
11/10/2010EP2247252A2 Method for treating stress urinary incontinence and symptomatic pelvic relaxation
11/10/2010EP1039882B1 Therapeutic formulation for administering tolterodine with controlled release
11/10/2010CN201625210U Tablet capsule filled with Dutasteride tablet and Tamsulosin tablet
11/10/2010CN1984900B Indole derivatives having piperidine rings
11/10/2010CN1965839B Sustained release microsphere of finasteride and its analogue, preparation process and use thereof
11/10/2010CN1939330B Medical usage of milkvetch-root methcoside
11/10/2010CN1919254B Pharmaceutical compositions and its application
11/10/2010CN101883765A Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
11/10/2010CN101880283A Azaindole kinase inhibitors
11/10/2010CN101879310A Application of human urinary kallidinogenase in preparing medicine for treating diabetic nephropathy
11/10/2010CN101879308A Application of human urinary kallidinogenase in preparing medicine for treating acute renal failureacute renal failure
11/10/2010CN101879297A Prostate recovery capsules of Chinese medicinal compound preparation, preparation process and application thereof
11/10/2010CN101879290A Chinese medicinal composition and application thereof
11/10/2010CN101879289A Novel use of composition for nourishing kidney, replenishing vital essence, promoting mentality and calming nerves
11/10/2010CN101879288A Chinese medicinal formula for treating hydronephrosis
11/10/2010CN101879280A Composition for nourishing kidney, replenishing vital essence, promoting mentality and calming nerves, and preparation method
11/10/2010CN101879276A Health wine for invigorating kidney and strengthening yang
11/10/2010CN101879264A Chinese medicinal composition for reducing blood uric acid
11/10/2010CN101879263A Application in prevention and treatment of urinary stone of compound preparation of six ingredients with rehmannia
11/10/2010CN101879237A Chinese medicinal composition for external use and preparation method thereof
11/10/2010CN101879197A Turpinia Montana leaf ethanol reflux extractive, preparation method and application thereof
11/10/2010CN101879156A Medicinal composition and application thereof
11/10/2010CN101879154A Prostate repairing medicament formed by matching alpha-ricinoleic acid ethyl ester with lycopene
11/10/2010CN101366896B Traditional Chinese medicine for treating chronic prostatitis and preparation method thereof
11/10/2010CN101171249B Method for producing indole derivative having piperidine ring
11/10/2010CN101073659B Chinese-herb-medicinal oral preparation for treating lithangiuria and cholecystolithiasis
11/10/2010CN101039902B Aminoalcohol derivatives
11/10/2010CN101002796B Application of nanometer montmorillonite for pharmaceutical use, and medicine compositions therewith
11/09/2010US7829596 administering to the patient an effective amount of a xanthine oxidase inhibitor ( allopurinol, 7,8-dihydroneopterin, 5,6,7,8-tetrahydrobiopterin, leukopterin, xanthopterin, neopterin etc.) to reduce sympathetic nervous system activity and/or improving cardiovascular reflex status for treating cachexia
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829545 Bladder and lower urinary tract syndromes, particularly, irrative symptoms, and to a method of treating same using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists. The invention further relates to a method of screening compounds
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010CA2484188C Tachykinin receptor antagonists
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 562